Literature DB >> 15829290

L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?

John J Haddad1, Hisham L Harb.   

Abstract

Of the antioxidant/prooxidant mechanisms mediating the regulation of inflammatory mediators, particularly cytokines, oxidative stress-related pathways remain a cornerstone. It is conspicuous that there is a strong association between free radical accumulation (ROS/RNS; oxidative stress) and the evolution of inflammation and inflammatory-related responses. The scenario that upholds a consensus on the aforementioned is still evolving to unravel, from an immunologic perspective, the molecular mechanisms associated with ROS/RNS-dependent inflammation. Cytokines are keynote players when it comes to defining an intimate relationship among reduction-oxidation (redox) signals, oxidative stress and inflammation. How close we are to identifying the molecular basis of this intricate association should be weighed against the involvement of specific signaling molecules and, potentially, transcription factors. L-gamma-Glutamyl-L-cysteinyl-glycine, or glutathione (GSH), an antioxidant thiol, has shaped, and still is refining, the face of oxidative signaling in terms of regulating the milieu of inflammatory mediators, ostensibly via the modulation (expression/repression) of oxygen- and redox-responsive transcription factors, hence termed redox(y)-sensitive cofactors. When it comes to the arena of oxygen sensing, oxidative stress and inflammation, nuclear factor-kappaB (NF-kappaB) and hypoxia-inducible factor-1alpha (HIF-1alpha) are key players that determine antioxidant/prooxidant responses with oxidative challenge. It is the theme therein to underlie current understanding of the molecular association hanging between oxidative stress and the evolution of inflammation, walked through an elaborate discussion on the role of transcription factors and cofactors. Would that classify glutathione and other redox signaling cofactors as potential anti-inflammatory molecules emphatically remains of particular interest, especially in the light of identifying upstream and downstream molecular pathways for conceiving therapeutic, alleviating strategy for oxidant-mediated, inflammatory-related disease conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15829290     DOI: 10.1016/j.molimm.2004.09.029

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  38 in total

1.  Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen.

Authors:  Puangrat Yongvanit; Raynoo Thanan; Somchai Pinlaor; Paiboon Sithithaworn; Watcharin Loilome; Nisana Namwat; Anchalee Techasen; Somkid Dechakhamphu
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever.

Authors:  Ana Paula Oliveira Ferreira; Juliana Saibt Martins Pasin; André Luis Lopes Saraiva; Viviane Ratzlaff; Mateus Fortes Rossato; Rosália Andrighetto; Maribel Antonello Rubin; Juliano Ferreira; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2011-11-08       Impact factor: 4.575

4.  Role of glutathione metabolism in host defense against Borrelia burgdorferi infection.

Authors:  Mariska Kerstholt; Hedwig Vrijmoeth; Ekta Lachmandas; Marije Oosting; Mihaela Lupse; Mirela Flonta; Charles A Dinarello; Mihai G Netea; Leo A B Joosten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-14       Impact factor: 11.205

5.  Toll-like receptors as a target of food-derived anti-inflammatory compounds.

Authors:  Takahiro Shibata; Fumie Nakashima; Kazuya Honda; Yu-Jhang Lu; Tatsuhiko Kondo; Yusuke Ushida; Koichi Aizawa; Hiroyuki Suganuma; Sho Oe; Hiroshi Tanaka; Takashi Takahashi; Koji Uchida
Journal:  J Biol Chem       Date:  2014-10-07       Impact factor: 5.157

Review 6.  Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase.

Authors:  Christopher C Franklin; Donald S Backos; Isaac Mohar; Collin C White; Henry J Forman; Terrance J Kavanagh
Journal:  Mol Aspects Med       Date:  2008-09-06

7.  Lipopolysaccharide from Escherichia coli prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence.

Authors:  Antoniella Souza Gomes; Henrique Paula Lemos; Jand Venes Rolim Medeiros; Fernando Queiroz Cunha; Marcellus Henrique Loiola Ponte Souza
Journal:  Inflamm Res       Date:  2009-04-29       Impact factor: 4.575

8.  Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages.

Authors:  Cheng-Sue Chang; Hai-Lun Sun; Chong-Kuei Lii; Haw-Wen Chen; Pei-Yin Chen; Kai-Li Liu
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

9.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl3-induced toxicity in the rat forebrain cortex.

Authors:  Ivana D Stevanović; Marina D Jovanović; Ankica Jelenković; Miodrag Colić; Ivana Stojanović; Milica Ninković
Journal:  J Vet Sci       Date:  2009-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.